Pages that link to "Q74597848"

The following pages link to Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: relationship to treatment method and atherosclerotic disease (Q74597848):

Displaying 49 items.

• Effect of diet and omega-3 fatty acid intervention on asymmetric dimethylarginine (Q21245073) (← links)
• Endothelial cell dysfunction and the vascular complications associated with type 2 diabetes: assessing the health of the endothelium (Q28219326) (← links)
• Total nitric oxide production is low in patients with chronic renal disease (Q28344716) (← links)
• Carotid intima-media thickness and plasma asymmetric dimethylarginine in Mexican children exposed to inorganic arsenic (Q28388163) (← links)
• A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with insulin sensitivity (Q28730293) (← links)
• [Clinical issues with uremia]. (Q30318078) (← links)
• Assessment of metabolomic and proteomic biomarkers in detection and prognosis of progression of renal function in chronic kidney disease (Q33591146) (← links)
• Asymmetrical dimethylarginine in renal disease: limits of variation or variation limits? A systematic review (Q33646665) (← links)
• Dimethylarginine metabolism during acute and chronic rejection of rat renal allografts (Q34426973) (← links)
• Peripheral Vascular Dysfunction in Chronic Kidney Disease (Q35012914) (← links)
• Iron overdose: a contributor to adverse outcomes in randomized trials of anemia correction in CKD (Q35857178) (← links)
• L-arginine and asymmetric dimethylarginine are early predictors for survival in septic patients with acute liver failure (Q35961528) (← links)
• Mechanism of cellular oxidation stress induced by asymmetric dimethylarginine (Q36097000) (← links)
• Vasculoprotective Effects of Dietary Cocoa Flavanols in Patients on Hemodialysis: A Double-Blind, Randomized, Placebo-Controlled Trial (Q36432925) (← links)
• Apolipoprotein E polymorphism modulation of asymmetric dimethylarginine in hypertensive patients is determined by renal function (Q36481807) (← links)
• Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: impact on nitric oxide metabolism (Q36536026) (← links)
• Arginine, arginine analogs and nitric oxide production in chronic kidney disease (Q36577145) (← links)
• Coronary artery calcification, ADMA, and insulin resistance in CKD patients (Q36843377) (← links)
• Regulation and prognostic relevance of symmetric dimethylarginine serum concentrations in critical illness and sepsis (Q37015522) (← links)
• Plasma ADMA predicts restenosis of arteriovenous fistula. (Q37042201) (← links)
• eNOS Glu298Asp Polymorphism and Endothelial Dysfunction in Patients with and without End-stage Renal Disease (Q37047148) (← links)
• Blood content of asymmetric dimethylarginine: new insights into its dysregulation in renal disease (Q37324434) (← links)
• Inflammation in chronic kidney disease: role in the progression of renal and cardiovascular disease (Q37350777) (← links)
• Arterial stiffness in dialysis patients: where are we now? (Q37635015) (← links)
• Hypertension in diabetic nephropathy: epidemiology, mechanisms, and management (Q37827620) (← links)
• Hypertension and hemodialysis: pathophysiology and outcomes in adult and pediatric populations (Q37834373) (← links)
• Cardiovascular risk biomarkers in CKD: the inflammation link and the road less traveled (Q38042361) (← links)
• Asymmetric dimethylarginine, endothelial dysfunction and renal disease (Q38056493) (← links)
• Risk of cardiovascular diseases in diabetes mellitus and serum concentration of asymmetrical dimethylarginine (Q39321647) (← links)
• Effects of asymmetric dimethylarginine on renal arteries in portal hypertension and cirrhosis. (Q40038186) (← links)
• Effect of enzyme replacement therapy on serum asymmetric dimethylarginine levels, coronary flow reserve and left ventricular hypertrophy in patients with Fabry disease (Q41364439) (← links)
• The inhibitory effect of quercetin on asymmetric dimethylarginine-induced apoptosis is mediated by the endoplasmic reticulum stress pathway in glomerular endothelial cells (Q41869460) (← links)
• Actin cytoskeleton modulates ADMA-induced NF-kappaB nuclear translocation and ICAM-1 expression in endothelial cells (Q42026688) (← links)
• Plasma from ESRD patients inhibits nitric oxide synthase activity in cultured human and bovine endothelial cells (Q42134568) (← links)
• The relationship of plasma ADMA levels with cardiac functions and metabolic parameters in peritoneal dialysis patients (Q42285086) (← links)
• Oxidative Stress in Hemodialysis Patients: A Review of the Literature. (Q43375953) (← links)
• Atherosclerosis and uremia: signifance of non-traditional risk factors (Q44460931) (← links)
• Are levels of NT-proBNP and SDMA useful to determine diastolic dysfunction in chronic kidney disease and renal transplant patients? (Q44653202) (← links)
• Pre-clinical model of severe glutathione peroxidase-3 deficiency and chronic kidney disease results in coronary artery thrombosis and depressed left ventricular function (Q46240455) (← links)
• Asymmetric dimethylarginine downregulates sarco/endoplasmic reticulum calcium‑ATPase 3 and induces endoplasmic reticulum stress in human umbilical vein endothelial cells (Q47749474) (← links)
• Pathophysiological, cardiovascular and neuroendocrine changes in hypertensive patients during the hemodialysis session. (Q48477559) (← links)
• Serum asymmetric dimethylarginine (ADMA), homocysteine, vitamin B(12), folate levels, and lipid profiles in epileptic children treated with valproic acid (Q51384965) (← links)
• Asymmetric dimethylarginine is not elevated in exfoliation syndrome but symmetric dimethylarginine is related to exfoliative glaucoma (Q51488191) (← links)
• Oxidative Stress in Patients Undergoing Peritoneal Dialysis: A Current Review of the Literature. (Q55228680) (← links)
• Targeted Metabolomic Profiling of Peritoneal Dialysis Effluents Shows Anti-oxidative Capacity of Alanyl-Glutamine (Q61812364) (← links)
• [Therapy and prophylaxis of renal failure] (Q79314860) (← links)
• Elevated preoperative serum asymmetrical dimethylarginine (ADMA) is associated with poor outcomes after pediatric cardiac surgery (Q84755621) (← links)
• Asymmetric (ADMA) and Symmetric (SDMA) Dimethylarginines in Chronic Kidney Disease: A Clinical Approach (Q92257110) (← links)
• Hypertension in patients on dialysis: diagnosis, mechanisms, and management (Q93026533) (← links)